Armadillo quads may help explain why identical twins differ – STAT
Studying details of armadillo genetics might reveal whether genes are as fateful as the current infatuation with genetic testing seems to assume.
Related Articles
Novavax wins narrowed approval for its Covid-19 shot after delay
Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA’s Marty Makary.
At gene therapy meeting, no one wants to talk about the Vinay Prasad (not) in the room
At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change FDA policy.
Does the CDC have an acting director?
Health secretary RFK Jr. earlier this week said it’s Matthew Buzzelli, listed on the CDC’s website as chief of staff. But the situation is a…
MAHA has a new think tank. The Trump administration is listening
The Make America Healthy Again movement is coalescing around a new effort to turn its goals into federal policy. The Trump administration is listening.
Trump is moving to terminate hundreds of federal grants across Harvard
Research into breast cancer, infectious diseases, longevity, and ALS is at risk.
FDA clears first blood test for diagnosing Alzheimer’s
The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for patients
Day 3 at ASGCT: Vinay Prasad speculation, screening newborns, promising data
A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad’s appointment might mean for approvals in rare disease treatments.
Does the CDC have an acting director?
Health secretary RFK Jr. earlier this week said it’s Matthew Buzzelli, listed on the CDC’s website as chief of staff. But the situation is a…
At gene therapy meeting, no one wants to talk about the Vinay Prasad (not) in the room
At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change FDA policy.
FDA clears first blood test for diagnosing Alzheimer’s
The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for patients